Yurong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yurong Zhang has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Chen Liang
Shanghai Key Laboratory of Crime Scene Evidence, Shanghai Institute of Forensic Science, Shanghai 200083, China
17 shared publicationsRong Wang
Shanghai Key Laboratory of Crime Scene Evidence, Shanghai Institute of Forensic Science, Shanghai 200083, China
17 shared publicationsChunfang Ni
Shanghai Key Laboratory of Crime Scene Evidence, Shanghai Institute of Forensic Science, Shanghai 200083, China
11 shared publicationsRu Lian
Shanghai Key Laboratory of Crime Scene Evidence, Shanghai Institute of Forensic Science, Shanghai 200083, China
7 shared publications- Yulan Rao
Fudan University
7 shared publications Haiying Ye
Shanghai Institute of Forensic Science, Shanghai Key Laboratory of Crime Scene Evidence, Shanghai, P. R. China
6 shared publications
Latest Publications
- Open Access
- 12 January 2026
- Published by Springer Nature in Research Square
Oral Pathological Features in Methamphetamine Users in Eastern China
Background Methamphetamine (METH), a highly addictive stimulant, is associated with severe oral health consequences termed “METH Mouth”. Numerous studies have shown that METH is associated with dental diseases, but no study has systematically elucidated the distribution of root caries among METH users. Meanwhile, wastewater analysis indicated lower METH consumption in China compared to other regions, yet whether this is correlated with reduced impact on oral health remained unexplored. Methods 32 male METH users were recruited in a detoxification center in an eastern China city, while 32 matched-pair participants were recruited as controls. The categories of decayed teeth (DT), missing teeth (MT), filled teeth (FT), decayed, missing, filled teeth (DMFT) index, dental plaque, and pH of saliva were recorded. Information such as oral habits and dietary exposure was collected via questionnaire and analyzed. Results Compared to the control group, the METH cohort demonstrated significantly lower salivary pH ( P = 0.011), higher systematic diseases prevalence ( P < 0.001), and elevated xerostomia incidence ( P = 0.006). Significant intergroup disparities were observed in DT ( P = 0.041) and DMFT indices ( P = 0.027) between the two groups. Within the METH group, MT was correlated with age ( P = 0.005) and brushing frequency ( P = 0.026), with root surface caries exclusively detected (mean decayed surfaces:1.53 ± 2.44) and exhibiting a predilection for the premolars and maxillary anterior teeth area. Conclusions The 32 studied METH users in eastern China demonstrated significantly poorer caries status and a higher systemic disease burden than the controls. They exhibited heightened susceptibility to root caries, with predilection for premolar and maxillary anterior regions. Reduced tooth brushing frequency was identified as a key risk factor for their exacerbated caries profile. These Chinese METH users showed less severity of oral health impairments than users in higher METH consumption regions in the world.
- 12 January 2026
- Published by Springer Nature in Research Square
Open AccessOral Pathological Features in Methamphetamine Users in Eastern China
Background Methamphetamine (METH), a highly addictive stimulant, is associated with severe oral health consequences termed “METH Mouth”. Numerous studies have shown that METH is associated with dental diseases, but no study has systematically elucidated the distribution of root caries among METH users. Meanwhile, wastewater analysis indicated lower METH consumption in China compared to other regions, yet whether this is correlated with reduced impact on oral health remained unexplored. Methods 32 male METH users were recruited in a detoxification center in an eastern China city, while 32 matched-pair participants were recruited as controls. The categories of decayed teeth (DT), missing teeth (MT), filled teeth (FT), decayed, missing, filled teeth (DMFT) index, dental plaque, and pH of saliva were recorded. Information such as oral habits and dietary exposure was collected via questionnaire and analyzed. Results Compared to the control group, the METH cohort demonstrated significantly lower salivary pH ( P = 0.011), higher systematic diseases prevalence ( P < 0.001), and elevated xerostomia incidence ( P = 0.006). Significant intergroup disparities were observed in DT ( P = 0.041) and DMFT indices ( P = 0.027) between the two groups. Within the METH group, MT was correlated with age ( P = 0.005) and brushing frequency ( P = 0.026), with root surface caries exclusively detected (mean decayed surfaces:1.53 ± 2.44) and exhibiting a predilection for the premolars and maxillary anterior teeth area. Conclusions The 32 studied METH users in eastern China demonstrated significantly poorer caries status and a higher systemic disease burden than the controls. They exhibited heightened susceptibility to root caries, with predilection for premolar and maxillary anterior regions. Reduced tooth brushing frequency was identified as a key risk factor for their exacerbated caries profile. These Chinese METH users showed less severity of oral health impairments than users in higher METH consumption regions in the world.
- 18 December 2023
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 35 (1) , 40-49
Automatic MDSPE Combined with DART–HRMS for the Rapid Quantitation of 21 Synthetic Cathinones in Urine
A new, rapid, and automated method for the quantitation of 21 synthetic cathinones in urine was established using magnetic dispersive solid-phase extraction (MDSPE) in combination with direct analysis in real time-high-resolution mass spectrometry (DART-HRMS). Sample preparation and quantitation were verified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Methcathinone-D3, α-PVP-D8, and proadifen (SKF525A) were used as internal standards. Magnetic HLB extractant and NaH2PO4/NaOH buffer (0.2 M, pH 7) were used in automatic MDSPE. All 21 synthetic cathinones could be detected and analyzed by DART-HRMS in under 1 min. It was proven that the linearities of 21 synthetic cathinones were suitable (R2 > 0.99) in the concentration ranges of 0.5-100 ng/mL or 1-100 ng/mL. The precision and accuracy values were all within ±15%, and the samples were stable under various conditions. The average time of each sample from preprocessing to completion of detection was approximately 2 min, allowing for rapid sample analysis. The relative error (RE) of the concentrations obtained by DART-HRMS and LC-MS/MS were within ±13.61%, and the linear coefficient (R) was 0.9964. The results of DART-HRMS and LC-MS/MS provided equivalent values at the 95% confidence level. In summary, a simple, fast, and convenient quantitation method via DART-HRMS was established. This application can be utilized to reduce backlogs and promote rapid case processing.
- 18 December 2023
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 35 (1) , 40-49
Automatic MDSPE Combined with DART–HRMS for the Rapid Quantitation of 21 Synthetic Cathinones in Urine
A new, rapid, and automated method for the quantitation of 21 synthetic cathinones in urine was established using magnetic dispersive solid-phase extraction (MDSPE) in combination with direct analysis in real time-high-resolution mass spectrometry (DART-HRMS). Sample preparation and quantitation were verified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Methcathinone-D3, α-PVP-D8, and proadifen (SKF525A) were used as internal standards. Magnetic HLB extractant and NaH2PO4/NaOH buffer (0.2 M, pH 7) were used in automatic MDSPE. All 21 synthetic cathinones could be detected and analyzed by DART-HRMS in under 1 min. It was proven that the linearities of 21 synthetic cathinones were suitable (R2 > 0.99) in the concentration ranges of 0.5-100 ng/mL or 1-100 ng/mL. The precision and accuracy values were all within ±15%, and the samples were stable under various conditions. The average time of each sample from preprocessing to completion of detection was approximately 2 min, allowing for rapid sample analysis. The relative error (RE) of the concentrations obtained by DART-HRMS and LC-MS/MS were within ±13.61%, and the linear coefficient (R) was 0.9964. The results of DART-HRMS and LC-MS/MS provided equivalent values at the 95% confidence level. In summary, a simple, fast, and convenient quantitation method via DART-HRMS was established. This application can be utilized to reduce backlogs and promote rapid case processing.
- 27 November 2022
- Published by Springer Nature in Forensic Toxicology
- Vol. 41 (1) , 126-134
Rapid quantification of phenobarbital and barbital in human whole blood by liquid–liquid extraction combined with DART-orbitrap-HRMS
Purpose This study aims to develop and validate a rapid, simple, and efficient bioanalytical method for the simultaneous quantification of phenobarbital and barbital in human whole blood using liquid–liquid extraction combined with direct analysis in real time (DART) and high-resolution mass spectrometry (HRMS). Method Phenobarbital-d5 and aprobarbital were selected as internal standards (ISs) of phenobarbital and barbital, respectively. A mixed solvent of o-xylene and ethyl acetate at a ratio of 1:6 was used to extract analytes of interest and ISs from 100 μL of human whole blood samples. Phenobarbital and barbital were detected by DART-HRMS. The proposed method has been validated in accordance with United States Food and Drug Administration Guidelines for Bioanalytical Method Validation in terms of selectivity, linearity, accuracy, precision, matrix effect, recovery, stability, and dilution integrity. Results The lower limits of quantification (LLOQs) of phenobarbital and barbital were both 10 ng/mL. The linearities were in the range of 10–1000 ng/mL (R2 ≥ 0.99). The mean recovery values of phenobarbital and barbital were 99.7% and 88.1%, respectively. The interday and intraday precision values were less than 10.4%, and the interday and intraday accuracy values ranged from 87.6 to 106.7%. Furthermore, the validated method was applied to four cases of phenobarbital poisoning at the Shanghai Institute of Forensic Science. Conclusion The developed and fully validated method enabled the simultaneous quantification of phenobarbital and barbital in human whole blood and was successfully applied to authentic cases.
- 27 November 2022
- Published by Springer Nature in Forensic Toxicology
- Vol. 41 (1) , 126-134
Rapid quantification of phenobarbital and barbital in human whole blood by liquid–liquid extraction combined with DART-orbitrap-HRMS
Purpose This study aims to develop and validate a rapid, simple, and efficient bioanalytical method for the simultaneous quantification of phenobarbital and barbital in human whole blood using liquid–liquid extraction combined with direct analysis in real time (DART) and high-resolution mass spectrometry (HRMS). Method Phenobarbital-d5 and aprobarbital were selected as internal standards (ISs) of phenobarbital and barbital, respectively. A mixed solvent of o-xylene and ethyl acetate at a ratio of 1:6 was used to extract analytes of interest and ISs from 100 μL of human whole blood samples. Phenobarbital and barbital were detected by DART-HRMS. The proposed method has been validated in accordance with United States Food and Drug Administration Guidelines for Bioanalytical Method Validation in terms of selectivity, linearity, accuracy, precision, matrix effect, recovery, stability, and dilution integrity. Results The lower limits of quantification (LLOQs) of phenobarbital and barbital were both 10 ng/mL. The linearities were in the range of 10–1000 ng/mL (R2 ≥ 0.99). The mean recovery values of phenobarbital and barbital were 99.7% and 88.1%, respectively. The interday and intraday precision values were less than 10.4%, and the interday and intraday accuracy values ranged from 87.6 to 106.7%. Furthermore, the validated method was applied to four cases of phenobarbital poisoning at the Shanghai Institute of Forensic Science. Conclusion The developed and fully validated method enabled the simultaneous quantification of phenobarbital and barbital in human whole blood and was successfully applied to authentic cases.
- 1 October 2021
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 13 (42) , 5048-5055
Rapid quantitation of three synthetic cathinones in urine by magnetic dispersive solid-phase extraction combined with DART-HRMS
For the rapid quantitation of three synthetic cathinones, namely 1-(4-chlorophenyl)-2-(1-pyrrolidinyl)pentan-1-one (4-Cl-α-PVP), 1-(4-methylphenyl)-2-(methylamino)pentan-1-one (4-MPD), and 1-(5,6,7,8-tetrahydronaphthalen-2-yl)-2-(1-pyrrolidinyl)pentan-1-one (β-TH-naphyrone), in urine, a new method was established using magnetic dispersive solid-phase extraction (MDSPE) combined with direct analysis in real time and high-resolution mass spectrometry (DART-HRMS). Methcathinone-D3 and proadifen (SKF525A) were used as the internal standards. Hydrophobic magnetic adsorbents were used and consisted of hydrophobic functional group (divinylbenzene) and hydrophilic functional group (vinylpyrrolidone) at a ratio of 3 : 1, and NaH2PO4//NaOH buffer (0.2 M, pH 7) was used in MDSPE. Detection was conducted by DART-HRMS in less than 1 min. For 4-Cl-α-PVP, 4-MPD and β-TH-Naphyrone, the limits of detection were 0.1 ng mL−1, 0.05 ng mL−1 and 0.1 ng mL−1, and the linear ranges were 0.5–100 ng mL−1, 0.2–100 ng mL−1 and 0.2–100 ng mL−1, respectively. The correlation coefficients were all greater than 0.99. The precision and deviation of accuracy were all within ±15%, and the stability of the samples was high under various conditions. The method was successfully applied to detect 4-Cl-α-PVP, 4-MPD and β-TH-naphyrone in rat urine after subcutaneous administration. In summary, a fast and convenient detection method was established, providing new and effective technical support for the rapid quantitation of three synthetic cathinones (4-Cl-α-PVP, 4-MPD and β-TH-Naphyrone) for forensic purposes.
- 1 October 2021
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 13 (42) , 5048-5055
Rapid quantitation of three synthetic cathinones in urine by magnetic dispersive solid-phase extraction combined with DART-HRMS
For the rapid quantitation of three synthetic cathinones, namely 1-(4-chlorophenyl)-2-(1-pyrrolidinyl)pentan-1-one (4-Cl-α-PVP), 1-(4-methylphenyl)-2-(methylamino)pentan-1-one (4-MPD), and 1-(5,6,7,8-tetrahydronaphthalen-2-yl)-2-(1-pyrrolidinyl)pentan-1-one (β-TH-naphyrone), in urine, a new method was established using magnetic dispersive solid-phase extraction (MDSPE) combined with direct analysis in real time and high-resolution mass spectrometry (DART-HRMS). Methcathinone-D3 and proadifen (SKF525A) were used as the internal standards. Hydrophobic magnetic adsorbents were used and consisted of hydrophobic functional group (divinylbenzene) and hydrophilic functional group (vinylpyrrolidone) at a ratio of 3 : 1, and NaH2PO4//NaOH buffer (0.2 M, pH 7) was used in MDSPE. Detection was conducted by DART-HRMS in less than 1 min. For 4-Cl-α-PVP, 4-MPD and β-TH-Naphyrone, the limits of detection were 0.1 ng mL−1, 0.05 ng mL−1 and 0.1 ng mL−1, and the linear ranges were 0.5–100 ng mL−1, 0.2–100 ng mL−1 and 0.2–100 ng mL−1, respectively. The correlation coefficients were all greater than 0.99. The precision and deviation of accuracy were all within ±15%, and the stability of the samples was high under various conditions. The method was successfully applied to detect 4-Cl-α-PVP, 4-MPD and β-TH-naphyrone in rat urine after subcutaneous administration. In summary, a fast and convenient detection method was established, providing new and effective technical support for the rapid quantitation of three synthetic cathinones (4-Cl-α-PVP, 4-MPD and β-TH-Naphyrone) for forensic purposes.
- 1 October 2020
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 44 (8) , 896-904
Alpha-Methylfentanyl and Beta-Hydroxyfentanyl LC-MS-MS Quantification in Rat Plasma after Long-Term Ethanol Exposure
Fentanyl and its analogues are highly abused drugs that dominate the illicit drug trade. alpha-Methylfentanyl (A-F) and beta-hydroxyfentanyl (B-F) are two fentanyl analogues that require the development of rapid detection technologies. The current study established and validated a rapid and high-sensitivity liquid chromatography-tandem mass spectrometry (LC-MS-MS) method to measure A-F and B-F concentrations in rat plasma following intravenous drug administration (20 mu g/kg). Because fentanyl is primarily metabolized by the liver, we evaluated the concentrations of A-F and B-F in vivo in rats, in a control group and a group with liver damage induced by 55 days of oral ethanol gavage (6.5 g/kg, 22.5% v/v). Liquid-liquid extraction and LC-MS-MS operating in the positive ion multiple reaction monitoring mode were used. A C-18 column was used, and the mobile phase consisted of 0.1% formic acid aqueous and acetonitrile. The limit of detection was 3 pg/mL (S/N > 5) for A-F and B-F. The calibration curves were linear within the concentration range of 0.01-5 ng/mL (R-2 = 0.9991) and 0.005-20 ng/mL (R-2 = 0.9999) for A-F and B-F, respectively. Extraction recoveries were 91.3%-97.6% with RSD <= 11.2% and 90.5%-94.3% with RSD <= 10.5% for A-F and B-F, respectively. Plasma matrix effects were 80.61%-84.58% for A-F and 80.67%-81.33% for B-F with RSD <= 13.9%. The validated assay indicated no significant differences in pharmacokinetic parameters (AUC(0-t), C-max and T-1/2) derived from the assessment of A-F and B-F plasma concentrations between control and ethanol-exposed rats. This assay, for which the LOD was 3 pg/mL for A-F and B-F may help the forensic science field to determine fentanyl analogue-related causes of death and identify illicit drug tampering.
- 1 October 2020
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 44 (8) , 896-904
Alpha-Methylfentanyl and Beta-Hydroxyfentanyl LC-MS-MS Quantification in Rat Plasma after Long-Term Ethanol Exposure
Fentanyl and its analogues are highly abused drugs that dominate the illicit drug trade. alpha-Methylfentanyl (A-F) and beta-hydroxyfentanyl (B-F) are two fentanyl analogues that require the development of rapid detection technologies. The current study established and validated a rapid and high-sensitivity liquid chromatography-tandem mass spectrometry (LC-MS-MS) method to measure A-F and B-F concentrations in rat plasma following intravenous drug administration (20 mu g/kg). Because fentanyl is primarily metabolized by the liver, we evaluated the concentrations of A-F and B-F in vivo in rats, in a control group and a group with liver damage induced by 55 days of oral ethanol gavage (6.5 g/kg, 22.5% v/v). Liquid-liquid extraction and LC-MS-MS operating in the positive ion multiple reaction monitoring mode were used. A C-18 column was used, and the mobile phase consisted of 0.1% formic acid aqueous and acetonitrile. The limit of detection was 3 pg/mL (S/N > 5) for A-F and B-F. The calibration curves were linear within the concentration range of 0.01-5 ng/mL (R-2 = 0.9991) and 0.005-20 ng/mL (R-2 = 0.9999) for A-F and B-F, respectively. Extraction recoveries were 91.3%-97.6% with RSD <= 11.2% and 90.5%-94.3% with RSD <= 10.5% for A-F and B-F, respectively. Plasma matrix effects were 80.61%-84.58% for A-F and 80.67%-81.33% for B-F with RSD <= 13.9%. The validated assay indicated no significant differences in pharmacokinetic parameters (AUC(0-t), C-max and T-1/2) derived from the assessment of A-F and B-F plasma concentrations between control and ethanol-exposed rats. This assay, for which the LOD was 3 pg/mL for A-F and B-F may help the forensic science field to determine fentanyl analogue-related causes of death and identify illicit drug tampering.
- 1 October 2018
- Published by Elsevier in Microchemical Journal
- Vol. 144, 403-410
Screening and quantitation of forty-six drugs of abuse and toxic compounds in human whole blood by capillary electrophoresis: Application to forensic cases
- 1 October 2018
- Published by Elsevier in Microchemical Journal
- Vol. 144, 403-410
Screening and quantitation of forty-six drugs of abuse and toxic compounds in human whole blood by capillary electrophoresis: Application to forensic cases
Simultaneous chiral analysis of amphetamine‐type stimulants and ephedrine by capillary electrophoresis coupled to time‐of‐flight mass spectrometry
This study focused on the chiral characteristics of methamphetamine seizures in Shanghai for inferring the synthetic pathways of drugs. Capillary electrophoresis coupled to time‐of‐flight mass spectrometry was used for simultaneous chiral separation of amphetamine‐type stimulants and ephedrine, including S(+)‐amphetamine/R(−)‐amphetamine, S(+)‐methamphetamine/R(−)‐methamphetamine, (±)‐MDA (3,4‐methylenedioxyamphetamine), (±)‐MDMA (3,4‐methylenedioxymethamphetamine), (±)‐MDEA (3,4‐methylenedioxy‐N‐ethylamphetamine), d,l‐N‐ethylamphetamine, methylephedrine/methylpseudoephedrine, and 1S,2R(+)‐ephedrine/(−)‐ephedrine. The running buffer was 50‐mM ammonium formate (pH 2.2 was adjusted by 1‐M formic acid) containing 0.26% highly sulfated γ‐cyclodextrin as the chiral selector. All enantiomers were well resolved within 40 minutes by capillary electrophoresis at 20 kV in an uncoated fused‐silica capillary (50‐μm I.D. × 375‐μm O.D. × 90‐cm length) and detected by micro time‐of‐flight mass spectrometry. Twenty seized methamphetamine samples were determined by the established method. They were classified into two groups through their chiral characteristics.
Simultaneous chiral analysis of amphetamine‐type stimulants and ephedrine by capillary electrophoresis coupled to time‐of‐flight mass spectrometry
This study focused on the chiral characteristics of methamphetamine seizures in Shanghai for inferring the synthetic pathways of drugs. Capillary electrophoresis coupled to time‐of‐flight mass spectrometry was used for simultaneous chiral separation of amphetamine‐type stimulants and ephedrine, including S(+)‐amphetamine/R(−)‐amphetamine, S(+)‐methamphetamine/R(−)‐methamphetamine, (±)‐MDA (3,4‐methylenedioxyamphetamine), (±)‐MDMA (3,4‐methylenedioxymethamphetamine), (±)‐MDEA (3,4‐methylenedioxy‐N‐ethylamphetamine), d,l‐N‐ethylamphetamine, methylephedrine/methylpseudoephedrine, and 1S,2R(+)‐ephedrine/(−)‐ephedrine. The running buffer was 50‐mM ammonium formate (pH 2.2 was adjusted by 1‐M formic acid) containing 0.26% highly sulfated γ‐cyclodextrin as the chiral selector. All enantiomers were well resolved within 40 minutes by capillary electrophoresis at 20 kV in an uncoated fused‐silica capillary (50‐μm I.D. × 375‐μm O.D. × 90‐cm length) and detected by micro time‐of‐flight mass spectrometry. Twenty seized methamphetamine samples were determined by the established method. They were classified into two groups through their chiral characteristics.
- 16 January 2018
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 10 (7) , 749-756
Ion mobility derived collision cross section as an additional measure to support the rapid analysis of abused drugs and toxic compounds using electrospray ion mobility time-of-flight mass spectrometry
Despite recent advances in analytical techniques, high-throughput and rapid screening of abused drugs and toxic compounds is imperative. In this study, a method hyphenating ion mobility spectrometry with high-resolution time-of-flight mass spectrometry (IM-TOF MS) was developed to measure commonly abused drugs and toxic compounds. IM spectrometry allows the measurement of the collision cross section (CCS) value while TOF MS provides the measurement of accurate mass. A total of 124 abused drugs and toxic compounds were evaluated. As a result, the experimental precision of the experimental CCS values was 0.25% or better and not affected by the processed matrices (∣ΔCCS∣blood ≤ 0.77% and ∣ΔCCS∣urine ≤ 0.93%). The experimental mass error was lower than 5 ppm. The screening limit of detection (LOD) was below 400 ng mL−1 for 93% of the test compounds in urine and 90% in blood. Finally, the method was applied to real samples from a local forensic laboratory and methamphetamine was identified successfully. It was demonstrated that IM-TOF MS was a promising approach for rapid screening of abused compounds and would increase the detection throughout.
- 16 January 2018
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 10 (7) , 749-756
Ion mobility derived collision cross section as an additional measure to support the rapid analysis of abused drugs and toxic compounds using electrospray ion mobility time-of-flight mass spectrometry
Despite recent advances in analytical techniques, high-throughput and rapid screening of abused drugs and toxic compounds is imperative. In this study, a method hyphenating ion mobility spectrometry with high-resolution time-of-flight mass spectrometry (IM-TOF MS) was developed to measure commonly abused drugs and toxic compounds. IM spectrometry allows the measurement of the collision cross section (CCS) value while TOF MS provides the measurement of accurate mass. A total of 124 abused drugs and toxic compounds were evaluated. As a result, the experimental precision of the experimental CCS values was 0.25% or better and not affected by the processed matrices (∣ΔCCS∣blood ≤ 0.77% and ∣ΔCCS∣urine ≤ 0.93%). The experimental mass error was lower than 5 ppm. The screening limit of detection (LOD) was below 400 ng mL−1 for 93% of the test compounds in urine and 90% in blood. Finally, the method was applied to real samples from a local forensic laboratory and methamphetamine was identified successfully. It was demonstrated that IM-TOF MS was a promising approach for rapid screening of abused compounds and would increase the detection throughout.